Skip to content

Managing Swelling (Lymphedema) in Patients: Homoeopathy Compared with Standard Treatment

Comparative study of individualised Homoeopathic medicines with standard line of treatment in management of Lymphedema - LYM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095491
Enrollment
104
Registered
2025-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I890- Lymphedema, not elsewhere classified

Interventions

Intervention1: Individualised Homoeopathic Medicine: Individualised Homoeopathic Medicine Dose: Depending on the laws of susceptibility, it will be Individualized dosage (from single dose to multipl

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed lymphedema (primary or secondary) by medical history, physical examination, and imaging studies. Severity: Mild, moderate, or severe lymphedema (Stage 0-3) Patients presenting with chronic or episodic Lymphedema symptoms such as Swelling, pain, heaviness, or limited mobility in affected limb Ability to provide informed consent and compley with the study

Exclusion criteria

Exclusion criteria: Pregnancy or lactation Severe systemic diseases (e.g., heart failure, severe kidney disease, severe liver disease) Limb amputation or severe trauma to affected limb

Design outcomes

Primary

MeasureTime frame
Change in the limb circumference from baseline to end of treatment at 12 weeks measured at standardised anatomical landmarks.Timepoint: Baseline ,4 weeks ,8 weeks and 12 weeks

Secondary

MeasureTime frame
Quality of life , change in disease specific quality of life(LYMQOL)questionnaireTimepoint: Change in quality of life from baseline to end of treatment at 12 weeks

Countries

India

Contacts

Public ContactDrDharmendra Sharma

Dr.D.Y.Patil Homoeopathic Medical College and research centre,Pune

pc.nayanaparmar@gmail.com9850587928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026